The largest database of trusted experimental protocols

Hlc 723g8 hplc analyzer

Manufactured by Tosoh
Sourced in Japan

The HLC-723G8 HPLC analyzer is a high-performance liquid chromatography instrument manufactured by Tosoh. It is designed to perform analytical and preparative separation of complex mixtures. The HLC-723G8 utilizes a variety of detection methods to identify and quantify the components in a sample.

Automatically generated - may contain errors

2 protocols using hlc 723g8 hplc analyzer

1

Screening and Diagnosis of Hereditary Hemolytic Anemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
The annual number of routine PB smear examinations requested at the Department of Laboratory Medicine, Daejeon St. Mary’s Hospital (Daejeon, Republic of Korea) were 3534 in 2015, 4437 in 2016, 4677 in 2017, 4446 in 2018, and 4694 in 2019, respectively. If more than 50% abnormal or dysmorphic RBCs were observed upon the routine screening of peripheral blood smears, additional laboratory testing was performed for differential diagnosis. Briefly, an RBC autohemolysis test, RBC osmotic fragility test, and direct Coombs test were conducted to determine if hereditary elliptocytosis (HE), hereditary spherocytosis (HS), or hereditary stomatocytosis (HSt) was suspected. The high-performance liquid chromatography (HPLC) of hemoglobin (Hb) using an HLC-723G8 HPLC analyzer (Tosoh Co., Tokyo, Japan) was performed to characterize abnormal Hb variants such as HBA2, HbF, or other Hb fractions found commonly in beta thalassemia major (BTM) and beta thalassemia minor (BTm). A workflow for the screening and molecular diagnosis of suspected HHA is illustrated in Figure 1. Peripheral whole blood was collected from individuals with suspected HHA and their family members if available. Genomic DNA was extracted from peripheral blood leukocytes using a QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocols.
+ Open protocol
+ Expand
2

Endocrine Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
GH was measured by a two-site chemiluminescent immunometric assay (AutoDELFIA® hGH, PerkinElmer Life and Analytical Sciences, Wallac Oy), intra-assay CV: 5.3–6.5%, interassay CV: 5.7–6.2%, and sensitivity: up to 0.01 μg/l (0.026 mU/l).
IGF-1 was measured with the IMMULITE 2000 solid-phase, enzyme-labeled chemiluminescent immunometric assay (Siemens Healthcare Diagnostic Products Limited, UK); normal age-appropriate ranges are as follows: 1–6 years: 49–327 μg/l; 7–11 years: 57–551 μg/l; 12–13 years: 143–850 μg/l; 14–16 years: 220–996 μg/l; 17–18 years: 163–731 μg/l; 19–20 years: 127–483 μg/l; 21–35 years: 115–358 μg/l; 36–50 years: 94–284 μg/l; >50 years: 55–238 μg/l; intra-assay CV: 2.3–3.5%; interassay CV: 7.0–7.1%; and sensitivity: 20 μg/l. IGF-1 index = IGF − 1/upper limit of normal range (ULN) [24 (link)].
Insulin was measured by chemiluminescence immunoassay (ADVIA Centaur XP, Siemens, USA). BG was measured by a Hitachi 7600 Biochemical Analyzer (Tokyo, Japan). HbA1c was detected with high-performance liquid chromatography (Tosoh HLC-723 G8 HPLC Analyzer, Japan).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!